Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasant Chinnabhandar

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Indian Pediatrics|May 9, 2012
Rituximab usage in children: a double edged swordSatya Prakash Yadav, Vasant Chinnabhandar
Journal of Neurosciences in Rural Practice|October 2, 2018
Acute Hemiplegia in Children: A Prospective Study of Etiology, Clinical Presentation, and Outcome from Western IndiaVasant Chinnabhandar, Amitabh Singh, Anirban Mandal, et al.
Pediatric Hematology and Oncology|June 14, 2013
Primary immunodeficiency disorders in the developing world: data from a hospital-based registry in IndiaVasant Chinnabhandar, Satya Prakash Yadav, Dinesh Kaul, et al.
Pediatric Hematology and Oncology|January 4, 2014
Hemophagocytic lymphohistiocytosis in infants: a single center experience from IndiaMohammed Ramzan, Satya Prakash Yadav, Gaurav Kharya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2020
Addition of Thiotepa to Total Body Irradiation and Cyclophosphamide Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic LeukemiaVasant Chinnabhandar, Steven Tran, Rosemary Sutton, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2026
Targeted Therapy for Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of ChildhoodJonathan J Holzmann, Michael O'Sullivan, Adrian Charles, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Blood|September 9, 2021
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemiaJenna Rossoff, Christina Baggott, Snehit Prabhu, et al.
Blood Advances|August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortiumHeather E Stefanski, Anne Eaton, Christina Baggott, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Indian Pediatrics|May 9, 2012
Rituximab usage in children: a double edged swordSatya Prakash Yadav, Vasant Chinnabhandar
Journal of Neurosciences in Rural Practice|October 2, 2018
Acute Hemiplegia in Children: A Prospective Study of Etiology, Clinical Presentation, and Outcome from Western IndiaVasant Chinnabhandar, Amitabh Singh, Anirban Mandal, et al.
Pediatric Hematology and Oncology|June 14, 2013
Primary immunodeficiency disorders in the developing world: data from a hospital-based registry in IndiaVasant Chinnabhandar, Satya Prakash Yadav, Dinesh Kaul, et al.
Pediatric Hematology and Oncology|January 4, 2014
Hemophagocytic lymphohistiocytosis in infants: a single center experience from IndiaMohammed Ramzan, Satya Prakash Yadav, Gaurav Kharya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2020
Addition of Thiotepa to Total Body Irradiation and Cyclophosphamide Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic LeukemiaVasant Chinnabhandar, Steven Tran, Rosemary Sutton, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2026
Targeted Therapy for Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of ChildhoodJonathan J Holzmann, Michael O'Sullivan, Adrian Charles, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Blood|September 9, 2021
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemiaJenna Rossoff, Christina Baggott, Snehit Prabhu, et al.
Blood Advances|August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortiumHeather E Stefanski, Anne Eaton, Christina Baggott, et al.
Pageof 2